Track Orthofix Medical Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Orthofix Medical Inc. OFIX · Stock Open Orthofix Medical Inc. in new tab

12.26 USD
EPS
-1.50
P/B
1.15
ROE
-13.43
Beta
0.71
Target Price
15.50 USD
Loading chart...
Key Metrics
Earnings dateAug. 4, 2026
EPS-1.50
Book Value10.78
Price to Book1.15
Debt/Equity60.26
% Insiders2.194%
Growth
Revenue Growth0.02%
Estimates
Forward P/E14.74
Forward EPS0.84
Target Mean Price15.50

DCF Valuation

Tweak assumptions to recompute fair value for Orthofix Medical Inc. (OFIX)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Orthofix Medical Inc. Logo Orthofix Medical Inc. Analysis (OFIX)

United States Health Care Official Website Stock

Is Orthofix Medical Inc. a good investment? Orthofix Medical Inc. (OFIX) is currently trading at 12.26 USD. Market analysts have a consensus price target of 15.50 USD. This suggests a potential upside from current levels.

Earnings Schedule: Orthofix Medical Inc. is expected to release its next earnings report on Aug. 4, 2026. The market consensus estimate for Forward EPS is 0.84.

Investor FAQ

Does Orthofix Medical Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Orthofix Medical Inc.?

Orthofix Medical Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 4, 2026. The company currently has a trailing EPS of -1.50.

Company Profile

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Exchange Ticker
NMS (United States) OFIX
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion